Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial

被引：0
|
作者：
Aung Myat
Simon R. Redwood
Satpal Arri
Bernard J. Gersh
Deepak L. Bhatt
Michael S. Marber
机构：
[1] St Thomas’ Hospital,King’s College London British Heart Foundation Centre of Research Excellence, The Rayne Institute, Cardiovascular Division
[2] Frimley Park Hospital,Department of Cardiovascular Medicine
[3] Frimley Health NHS Foundation Trust,undefined
[4] Mayo Clinic College of Medicine,undefined
[5] Brigham and Women’s Hospital Heart & Vascular Centre and Harvard Medical School,undefined
来源：
Diabetology & Metabolic Syndrome | / 13卷
关键词：
Liraglutide; Glucagon-like peptide-1 receptor agonist; Myocardial ischaemia; Chronic stable angina; Coronary artery disease; Incretin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial
    Myat, Aung
    Redwood, Simon R.
    Arri, Satpal
    Gersh, Bernard J.
    Bhatt, Deepak L.
    Marber, Michael S.
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01):
  • [2] Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
    Myat, Aung
    Arri, Satpal
    Bhatt, Deepak L.
    Gersh, Bernard J.
    Redwood, Simon R.
    Marber, Michael S.
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [3] Design and rationale for the randomised, double-blinded, placebo-controlled Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS) crossover study
    Aung Myat
    Satpal Arri
    Deepak L Bhatt
    Bernard J Gersh
    Simon R Redwood
    Michael S Marber
    Cardiovascular Diabetology, 14
  • [4] MODAFINIL EFFECTS DURING ACUTE CPAP WITHDRAWAL: A RANDOMISED CROSSOVER DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    Williams, S. C.
    Marshall, N. S.
    Liu, P. Y.
    Rogers, N. L.
    Grunstein, R. R.
    SLEEP, 2009, 32 : A209 - A209
  • [5] Gabapentin for Parkinsonism: A double-blind, placebo-controlled, crossover trial
    Olson, WL
    Gruenthal, M
    Mueller, ME
    Olson, WH
    AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01): : 60 - 66
  • [6] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
    Astrup, Arne
    Rossner, Stephan
    Van Gaal, Luc
    Rissanen, Aila
    Niskanen, Leo
    Al Hakim, Mazin
    Madsen, Jesper
    Rasmussen, Mads F.
    Lean, Michael E. J.
    LANCET, 2009, 374 (9701): : 1606 - 1616
  • [7] A Randomised, Double-Blind, Placebo-Controlled Crossover Trial of Resveratrol Supplementation for Prophylaxis of Hormonal Migraine
    Dzator, Jemima S. A.
    Howe, Peter R. C.
    Coupland, Kirsten G.
    Wong, Rachel H. X.
    NUTRIENTS, 2022, 14 (09)
  • [8] The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
    Laurence Lion-François
    François Gueyffier
    Catherine Mercier
    Daniel Gérard
    Vania Herbillon
    Isabelle Kemlin
    Diana Rodriguez
    Tiphanie Ginhoux
    Emeline Peyric
    Virginie Coutinho
    Valentine Bréant
    Vincent des Portes
    Stéphane Pinson
    Patrick Combemale
    Behrouz Kassaï
    Orphanet Journal of Rare Diseases, 9
  • [9] The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
    Lion-Francois, Laurence
    Gueyffier, Francois
    Mercier, Catherine
    Gerard, Daniel
    Herbillon, Vania
    Kemlin, Isabelle
    Rodriguez, Diana
    Ginhoux, Tiphanie
    Peyric, Emeline
    Coutinho, Virginie
    Breant, Valentine
    des Portes, Vincent
    Pinson, Stephane
    Combemale, Patrick
    Kassai, Behrouz
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 : 142
  • [10] Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial
    Brown, SGA
    Wiese, MD
    Blackman, KE
    Heddle, RJ
    LANCET, 2003, 361 (9362): : 1001 - 1006
12345